Valeant Pharmaceuticals Maximizing Profits: Is it News?
Recently, Valeant Pharmaceuticals were lambasted for their malicious business strategies in front of the Senate Special Committee on Aging at a congressional hearing. Â Their practice may be considered malevolent but it does not change the fact that numerous other pharmaceutical companies participate in the same practices to maximize their profits. What Valeant executives fail to […]
